Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia : The Pros and Cons

المؤلفون المشاركون

Yang, Yen Kuang
Chung, Young-Chul
Lee, Sang-Hyuk
Park, Jong-Il
Kim, Borah

المصدر

Schizophrenia Research and Treatment

العدد

المجلد 2012، العدد 2012 (31 ديسمبر/كانون الأول 2012)، ص ص. 1-8، 8ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2012-08-27

دولة النشر

مصر

عدد الصفحات

8

التخصصات الرئيسية

الأمراض

الملخص EN

Clinical and psychosocial deterioration associated with schizophrenia occurs within the first few years following the onset of the illness.

Therefore, to improve the long-term prognosis, it is important to provide schizophrenia patients with intensive treatment following their first episode.

Relapse is highly associated with partial medication adherence or nonadherence in patients with first-episode schizophrenia.

Recent studies suggest that long-acting injectable (LAI) antipsychotics compared with oral antipsychotics are more effective for medication adherence and relapse prevention.

Moreover, some clinical guidelines for the treatment of schizophrenia suggested that LAI antipsychotics should be considered when patients are nonadherent “at any stage.” Decreased compliance is a common cause of relapse during the initial stages of the disease.

Therefore, LAI antipsychotics should be highly considered when treating patients with first-episode schizophrenia.

In the present paper, clinical trial data and current guidelines on the use of LAI antipsychotics for first-episode schizophrenia are discussed as well as the pros and cons of this treatment option.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Kim, Borah& Lee, Sang-Hyuk& Yang, Yen Kuang& Park, Jong-Il& Chung, Young-Chul. 2012. Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia : The Pros and Cons. Schizophrenia Research and Treatment،Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-480813

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Kim, Borah…[et al.]. Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia : The Pros and Cons. Schizophrenia Research and Treatment No. 2012 (2012), pp.1-8.
https://search.emarefa.net/detail/BIM-480813

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Kim, Borah& Lee, Sang-Hyuk& Yang, Yen Kuang& Park, Jong-Il& Chung, Young-Chul. Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia : The Pros and Cons. Schizophrenia Research and Treatment. 2012. Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-480813

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-480813